Epigenetics Diagnostic Market

Epigenetics Diagnostic Market Size, Share & Trends Analysis Report and
Segment Forecast, 2026| Grand View Research, Inc
“The global epigenetics diagnostic market size was valued at USD 5.5 billion in
2018 and is estimated to register a CAGR of 18.8% over the forecast period.”
The global Epigenetics Diagnostic Market size is expected to reach USD 21.7 billion by 2026, expanding at a
CAGR of 18.8% over the forecast period, according to a new study by Grand View Research, Inc. Growing
prevalence of cancer and other diseases across the globe, along with epigenetic modification base, is
anticipated to fuel the industry growth during the forecast period.
Diagnostic companies are upgrading their products by implementing new techniques for attaining specific and
sensitive results. Companies such as Abcam plc, Invitrogen, and Sigma Aldrich Corporation are developing a
new range of Chromatin immunoprecipitation (ChIP)-validated antibodies specific for detection of histone
modifications at various loci.
In addition, many biotechnology and pharmaceutical companies and academic research organizations are
collaborating to promote the growth of the epigenetics diagnostic industry. Companies such as Epigenomics,
OncoMethylome Sciences, and Orion Genomics have collaborated with other laboratories and diagnostic
companies that have licensed their technology for development of Laboratory-developed Tests (LDTs).
Follow Us:
Technological advancements resulting in increased accuracy, portability, and cost-effectiveness are expected to
be a high-impact rendering driver in the market. For instance, Diagenode has developed automated kits for
detection and purification of methylated DNA.
To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/epigenetics-diagnostic-market
Further key findings from the study suggest:

On the basis of product, reagents held the largest share owing to increasing R&D activities in field of
epigenetics. Kits are expected to witness high demand over the forecast period, expanding at a CAGR of
19.2% due to need for rapid and accurate detection techniques

Based on technology, DNA methylation held a major share in terms of revenue in 2018. Technological
advancements such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to
improve diagnostics efficiency are the factors attributing to its largest share

Growing prevalence of cancer with epigenetic modification is a key factor driving the oncology
application segment. Solid tumors further dominated the segment in 2018

North America emerged as a major regional market in 2018 due to factors such as high levels of patient
awareness, growing collaborations between large pharmaceutical firms for development of improved
therapeutics, increasing funding for R&D, and increasing cancer prevalence

The market in Asia Pacific is estimated to witness significant growth over the forecast period with a
CAGR of 20.9% owing to the presence of large target population having cancer, diabetes, and other
chronic disorders, along with parallel unmet clinical needs

Major players of the industry include Sigma-Aldrich Corporation; Valirx Plc; Oncolys Biopharma Inc.;
Zymo Research Corporation; Qiagen; Thermo Fisher Scientific; Diagenode Diagnostics; and Illumina, Inc.
Extensive R&D initiatives for development of novel drugs and presence of strong product pipeline are
expected to further boost the market growth over the forecast period.
Grand View Research has segmented the global epigenetics diagnostic market on the basis of product,
technology, application, and region:
Follow Us:
Epigenetics Diagnostic Product Outlook (Revenue, USD Million, 2014 - 2026)

Reagents

Kits
o
ChIP Sequencing Kit
o
Whole Genomic Amplification Kit
o
Bisulfite Conversion Kit
o
RNA Sequencing Kit
o
Others

Instruments

Enzymes

Services
Epigenetics Diagnostic Technology Outlook (Revenue, USD Million, 2014 - 2026)


DNA Methylation
o
Reagents
o
Kits
o
Instruments
o
Enzymes
o
Services
Histone Methylation
Follow Us:
o
Reagents
o
Kits
o
Instruments
o
Enzymes
o




Services
Histone Acetylation
o
Reagents
o
Kits
o
Instruments
o
Enzymes
o
Services
Large non-coding RNA
o
Reagents
o
Kits
o
Instruments
o
Enzymes
o
Services
MicroRNA modification
o
Reagents
o
Kits
o
Instruments
o
Enzymes
o
Services
Chromatin structures
Follow Us:
o
Reagents
o
Kits
o
Instruments
o
Enzymes
o
Services
Epigenetics Diagnostic Application Outlook (Revenue, USD Million, 2014 – 2026)


Oncology
o
Solid tumors
o
Liquid tumors
Non-oncology
o
Inflammatory diseases
o
Metabolic diseases
o
Infectious diseases
o
Cardiovascular diseases
o
Others
Epigenetics Diagnostic Regional Outlook (Revenue, USD Million, 2014 - 2026)



North America
o
U.S.
o
Canada
Europe
o
U.K.
o
Germany
o
Spain
o
France
o
Italy
o
Russia
Asia Pacific
Follow Us:


o
Japan
o
China
o
India
o
South Korea
o
Singapore
o
Australia
Latin America
o
Brazil
o
Mexico
o
Argentina
Middle East and Africa (MEA)
Follow Us:
o
South Africa
o
United Arab Emirates
o
Saudi Arabia
Table of Content of Epigenetics Diagnostic Market
Chapter 1 Research methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
i. Purchased database
ii. GVR’s internal database
iii. Secondary sources & third-party perspectives
iv. Primary research
1.4 Information analysis
i. Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive summary
2.1 Epigenetics Diagnostic Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Global Epigenetics Diagnostic Market Variables, Trends & Scope
3.1 Penetration & Growth Prospects Mapping
3.2 Regulatory Framework
3.2.1 Reimbursement framework
3.2.2 Standards & Compliances
3.3 Epigenetics Diagnostic Market Dynamics
3.3.1 Epigenetics Diagnostic Market Driver Analysis
3.3.1.1 Increasing prevalence of target diseases
3.3.1.2 Growing global geriatric population
3.3.1.3 Presence of funding programs to promote and support research & development
3.3.1.4 Technological advancements
3.3.2 Epigenetics Diagnostic Market Restraint Analysis
3.3.2.1 Inefficiency in identification and validation of biomarkers
Follow Us:
3.3.2.2 Presence of complex regulatory framework
3.4 Global Epigenetics Diagnostic Market Analysis Tool
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Supplier power (Low due to many manufacturers for diagnostic reagents)
3.4.1.2 Buyer power (Moderate due to various manufacturers in the market)
3.4.1.3 Substitution threat (Moderate due to introduction of new diagnostic kits)
3.4.1.4 New entrants threat (High due to high demand for novel techniques)
3.4.1.5 Competitive rivalry (High due to increasing acquisitions by players)
3.4.2 Epigenetics Diagnostic Market - SWOT by PEST Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.3.1 Joint Ventures
3.4.3.2 Mergers & Acquisitions
3.4.3.3 Licensing & Partnership
3.4.3.4 Technology Collaborations
3.4.3.5 Strategic Divestments Company market share analysis
Chapter 4 Global Epigenetics Diagnostic Market - Competitive Analysis
4.1 Recent developments & impact analysis, by key market participants
4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key
serviceable industries, key alliances)
4.4.2 Company Market Share
4.4.3 Competitive Dashboard Analysis
Follow Us:
4.4.4 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Regional network map
4.5.3 Company market position analysis (geographic presence, product portfolio, key alliance, industry
experience)
Chapter 5 Global Epigenetics Diagnostic Market: Product Estimates & Trend Analysis
5.1 Definition & Scope
5.2 Product market share analysis, 2018 & 2026
5.3 Global Epigenetics Diagnostic Market, by Product, 2014 to 2026
5.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
5.4.1 Epigenetics-based reagents market
5.4.1.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
5.4.2 Epigenetics-based kits market
5.4.2.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
5.4.2.2 ChIP sequencing kit market
5.4.2.2.1 ChIP sequencing kit market, 2014 to 2026 (USD Million)
5.4.2.3 Whole-genomic amplification kit market
5.4.2.3.1 Whole-genomic amplification kit market, 2014 to 2026 (USD Million)
5.4.2.4 Bisulfite conversion kit market
5.4.2.4.1 Bisulfite conversion kit market, 2014 to 2026 (USD Million)
5.4.2.5 RNA sequencing Kit market
5.4.2.5.1 RNA sequencing Kit market, 2014 to 2026 (USD Million)
5.4.2.6 Others market
5.4.2.6.1 Others market, 2014 to 2026 (USD Million)
5.4.3 Epigenetics-based instruments market
5.4.3.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
5.4.4 Epigenetics-based enzymes market
5.4.4.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
5.4.5 Epigenetics-based services market
5.4.5.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
Follow Us:
Chapter 6 Global Epigenetics Diagnostic Market: Technology Estimates & Trend Analysis
6.1 Definition & Scope
6.2 Technology market share analysis, 2018 & 2026
6.3 Global Epigenetics Diagnostic Market, by Technology, 2014 to 2026
6.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
6.4.1 Epigenetics-based DNA methylation market
6.4.1.1 Epigenetics-based DNA methylation market,2014 to 2026 (USD Million)
6.4.1.2 Epigenetics-based reagents market
6.4.1.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.1.3 Epigenetics-based kits market
6.4.1.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.1.4 Epigenetics-based instruments market
6.4.1.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.1.5 Epigenetics-based enzymes market
6.4.1.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.1.6 Epigenetics-based services market
6.4.1.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.2 Epigenetics-based histone methylation market
6.4.2.1 Epigenetics-based histone methylation market revenue (USD Million)
6.4.2.2 Epigenetics-based reagents market
6.4.2.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.2.3 Epigenetics-based kits market
6.4.2.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.2.4 Epigenetics-based instruments market
6.4.2.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.2.5 Epigenetics-based enzymes market
6.4.2.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.2.6 Epigenetics-based services market
6.4.2.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.3 Epigenetics-based histone acetylation market
6.4.3.1 Epigenetics-based enzymes Market revenue (USD Million)
Follow Us:
6.4.3.2 Epigenetics-based reagents market
6.4.3.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.3.3 Epigenetics-based kits market
6.4.3.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.3.4 Epigenetics-based instruments market
6.4.3.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.3.5 Epigenetics-based enzymes market
6.4.3.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.3.6 Epigenetics-based services market
6.4.3.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.4 Epigenetics-based long non-coding RNA market
6.4.4.1 Epigenetics-based long non-coding RNA market revenue (USD Million)
6.4.4.2 Epigenetics-based reagents market
6.4.4.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.4.3 Epigenetics-based kits market
6.4.4.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.4.4 Epigenetics-based instruments market
6.4.4.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.4.5 Epigenetics-based enzymes market
6.4.4.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.4.6 Epigenetics-based services market
6.4.4.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.5 Epigenetics-based microRNA modification market
6.4.5.1 Epigenetics-based microRNA modification market revenue (USD Million)
6.4.5.2 Epigenetics-based reagents market
6.4.5.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.5.3 Epigenetics-based kits market
6.4.5.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.5.4 Epigenetics-based instruments market
6.4.5.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.5.5 Epigenetics-based enzymes market
Follow Us:
6.4.5.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.5.6 Epigenetics-based services market
6.4.5.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.6 Epigenetics-based chromatin structures market
6.4.6.1 Epigenetics-based chromatin structures market revenue (USD Million)
6.4.6.2 Epigenetics-based reagents market
6.4.6.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.6.3 Epigenetics-based kits market
6.4.6.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.6.4 Epigenetics-based instruments market
6.4.6.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.6.5 Epigenetics-based enzymes market
6.4.6.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.6.6 Epigenetics-based services market
6.4.6.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
Chapter 7 Global Epigenetics Diagnostic Market: Application Estimates & Trend Analysis
7.1 Definition & Scope
7.2 Application market share analysis, 2018 & 2026
7.3 Global Epigenetics Diagnostic Market, by Application 2014 to 2026
7.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
7.4.1 Oncology market
7.4.1.1 Oncology market, 2014 to 2026 (USD Million)
7.4.1.2 Solid tumors market
7.4.1.2.1 Solid tumors market, 2014 to 2026 (USD Million)
7.4.1.3 Liquid tumors market
7.4.1.3.1 Liquid tumors market, 2014 to 2026 (USD Million)
7.4.2 Non-Oncology market
7.4.2.1 Non-Oncology market, 2014 to 2026 (USD Million)
7.4.2.2 Inflammatory disease market
7.4.2.2.1 Inflammatory disease market, 2014 to 2026 (USD Million)
7.4.2.3 Metabolic diseases kit market
Follow Us:
7.4.2.3.1 Metabolic diseases market, 2014 to 2026 (USD Million)
7.4.2.4 Infectious diseases market
7.4.2.4.1 Infectious diseases market, 2014 to 2026 (USD Million)
7.4.2.5 Cardiovascular diseases market
7.4.2.5.1 Cardiovascular diseases market, 2014 to 2026 (USD Million)
7.4.2.6 Others market
7.4.2.6.1 Others market, 2014 to 2026 (USD Million)
Chapter 8 Global Epigenetics Diagnostic Market: Regional Estimates & Trend Analysis, by Product, Technology &
Application
8.1 Global Epigenetics Diagnostic Market: Regional Movement Analysis, 2018 & 2026
8.2 Global IVD Market: Leading Players, 2018:
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa
8.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 North America
8.4.1 North America Epigenetics Diagnostic Market, 2014 - 2026 (USD Million)
8.4.2 U.S. Epigenetics Diagnostic Market
8.4.2.1 U.S. Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.4.3 Canada Epigenetics Diagnostic Market
8.4.3.1 Canada Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5 Europe
8.5.1 Europe Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.2 Germany Epigenetics Diagnostic Market
Follow Us:
8.5.2.1 Germany Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.3 U.K. Epigenetics Diagnostic Market
8.5.3.1 U.K. Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.4 Spain Epigenetics Diagnostic Market
8.5.4.1 Spain Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.5 France Epigenetics Diagnostic Market
8.5.5.1 France Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.6 Italy Epigenetics Diagnostic Market
8.5.6.1 Italy Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.7 Russia Epigenetics Diagnostic Market
8.5.7.1 Russia Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.2 Japan Epigenetics Diagnostic Market
8.6.2.1 Japan Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.3 China Epigenetics Diagnostic Market
8.6.3.1 China Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.4 India Epigenetics Diagnostic Market
8.6.4.1 India Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.5 South Korea Epigenetics Diagnostic Market
8.6.5.1 South Korea Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.6 Singapore Epigenetics Diagnostic Market
8.6.6.1 Singapore Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.7 Australia Epigenetics Diagnostic Market
8.6.7.1 Australia Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7 Latin America
8.7.1 Latin America Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7.2 Brazil Epigenetics Diagnostic Market
8.7.2.1 Brazil Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7.3 Mexico Epigenetics Diagnostic Market
8.7.3.1 Mexico Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
Follow Us:
8.7.4 Argentina Epigenetics Diagnostic Market
8.7.4.1 Argentina Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8 MEA
8.8.1 MEA Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8.2 South Africa Epigenetics Diagnostic Market
8.8.2.1 South Africa Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8.3 UAE Epigenetics Diagnostic Market
8.8.3.1 UAE Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8.4 Saudi Arabia Epigenetics Diagnostic Market
8.8.4.1 Saudi Arabia Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Company Profiles
9.2.1 Illumina, Inc.
9.2.1.1 Overview
9.2.1.2 Financial performance
9.2.1.3 Strategic initiatives
9.2.1.4 Product benchmarking
9.2.2 Merck Sharp & Dohme Corp
9.2.2.1 Overview
9.2.2.2 Financial performance
9.2.2.3 Strategic initiatives
9.2.2.4 Product benchmarking
9.2.3 Qiagen
9.2.3.1 Overview
9.2.3.2 Financial performance
9.2.3.3 Strategic initiatives
9.2.3.4 Product benchmarking
9.2.4 F. Hoffmann-La Roche Ltd.
9.2.4.1 Overview
9.2.4.2 Financial performance
Follow Us:
9.2.4.3 Strategic initiatives
9.2.4.4 Product benchmarking
9.2.5 Abcam plc
9.2.5.1 Overview
9.2.5.2 Financial performance
9.2.5.3 Strategic initiatives
9.2.5.4 Product benchmarking
9.2.6 Diagenode Diagnostics
9.2.6.1 Overview
9.2.6.2 Financial performance
9.2.6.3 Strategic initiatives
9.2.6.4 Product benchmarking
9.2.7 Thermo Fisher Scientific, Inc.
9.2.7.1 Overview
9.2.7.2 Financial performance
9.2.7.3 Strategic initiatives
9.2.7.4 Product benchmarking
9.2.8 Active Motif
9.2.8.1 Overview
9.2.8.2 Financial performance
9.2.8.3 Strategic initiatives
9.2.8.4 Product benchmarking
9.2.9 Zymo Research Corporation
9.2.9.1 Overview
9.2.9.2 Financial performance
9.2.9.3 Strategic initiatives
9.2.9.4 Product benchmarking
9.2.10 CellCentric
9.2.10.1 Overview
9.2.10.2 Strategic initiatives
9.2.10.3 Product benchmarking
Follow Us:
9.2.11 Valirx
9.2.11.1 Overview
9.2.11.2 Financial performance
9.2.11.3 Strategic initiatives
9.2.11.4 Product benchmarking
9.2.12 Sigma-Aldrich Corporation (Merck KGaA)
9.2.12.1 Overview
9.2.12.2 Financial performance
9.2.12.3 Strategic initiatives
9.2.12.4 Product benchmarking
Follow Us:
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

The global epigenetics diagnostic market size is expected to reach USD 21.7 billion by 2026

Download Report